BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18478020)

  • 1. Therapy-related acute myeloid leukaemia with mutated NPM1: treatment induced or de novo in origin?
    Falini B
    Leukemia; 2008 May; 22(5):891-2. PubMed ID: 18478020
    [No Abstract]   [Full Text] [Related]  

  • 2. NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?
    Pasqualucci L; Li S; Meloni G; Schnittger S; Gattenlohner S; Liso A; Di Ianni M; Martelli MP; Pescarmona E; Foa R; Haferlach T; Skoda RC; Falini B
    Leukemia; 2008 Jul; 22(7):1459-63. PubMed ID: 18200037
    [No Abstract]   [Full Text] [Related]  

  • 3. NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features.
    Andersen MT; Andersen MK; Christiansen DH; Pedersen-Bjergaard J
    Leukemia; 2008 May; 22(5):951-5. PubMed ID: 18273044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family.
    Cazzaniga G; Lo Nigro L; Cifola I; Milone G; Schnittger S; Haferlach T; Mirabile E; Costantino F; Martelli MP; Mastrodicasa E; Di Raimondo F; Aversa F; Biondi A; Falini B
    Leukemia; 2009 Jan; 23(1):199-203. PubMed ID: 18596743
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
    Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
    Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
    Falini B
    Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
    Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
    Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nucleophosmin in acute myeloid leukemia.
    Meani N; Alcalay M
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.
    Tiacci E; Venanzi A; Ascani S; Marra A; Cardinali V; Martino G; Codoni V; Schiavoni G; Martelli MP; Falini B
    N Engl J Med; 2018 Sep; 379(10):981-984. PubMed ID: 30184450
    [No Abstract]   [Full Text] [Related]  

  • 10. A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.
    Martelli MP; Manes N; Liso A; Pettirossi V; Verducci Galletti B; Bigerna B; Pucciarini A; De Marco MF; Pallotta MT; Bolli N; Sborgia M; di Raimondo F; Fabbiano F; Meloni G; Specchia G; Martelli MF; Falini B
    Leukemia; 2008 Dec; 22(12):2285-8. PubMed ID: 18563173
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor.
    Papadaki C; Dufour A; Seibl M; Schneider S; Bohlander SK; Zellmeier E; Mellert G; Hiddemann W; Spiekermann K
    Br J Haematol; 2009 Feb; 144(4):517-23. PubMed ID: 19055671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation.
    Choschzick M; Bacher U; Ayuk F; Lebeau A
    J Clin Pathol; 2010 Jun; 63(6):558-61. PubMed ID: 20360144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression.
    Kristensen T; Møller MB; Friis L; Bergmann OJ; Preiss B
    Eur J Haematol; 2011 Nov; 87(5):400-8. PubMed ID: 21707751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
    Krönke J; Schlenk RF; Jensen KO; Tschürtz F; Corbacioglu A; Gaidzik VI; Paschka P; Onken S; Eiwen K; Habdank M; Späth D; Lübbert M; Wattad M; Kindler T; Salih HR; Held G; Nachbaur D; von Lilienfeld-Toal M; Germing U; Haase D; Mergenthaler HG; Krauter J; Ganser A; Göhring G; Schlegelberger B; Döhner H; Döhner K
    J Clin Oncol; 2011 Jul; 29(19):2709-16. PubMed ID: 21555683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
    Zhang Y; Zhang M; Yang L; Xiao Z
    Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity.
    Kern W; Haferlach C; Bacher U; Haferlach T; Schnittger S
    Leukemia; 2009 Jul; 23(7):1361-4. PubMed ID: 19369962
    [No Abstract]   [Full Text] [Related]  

  • 18. Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability.
    Meloni G; Mancini M; Gianfelici V; Martelli MP; Foa R; Falini B
    Haematologica; 2009 Feb; 94(2):298-300. PubMed ID: 19181793
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of FLT3 mutational status and sustained expression of NPM1 mutation in paired presentation, and relapse samples in a patient with acute myeloid leukemia.
    Radojkovic M; Tosic N; Colovic N; Ristic S; Pavlovic S; Colovic M
    Ann Clin Lab Sci; 2012; 42(2):186-90. PubMed ID: 22585616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the association of "cup-like" nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful?
    Bennett JM; Pryor J; Laughlin TS; Rothberg PG; Burack WR
    Am J Clin Pathol; 2010 Oct; 134(4):648-52. PubMed ID: 20855646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.